P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

Eichhorst, B., Lamanna, N., O’brien, S., Tam, C., Qiu, L., Yang, K., Wu, K., Salmi, T., Barnes, G., & Brown, J. R. (2023). P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL). HemaSphere, 7(S3), e02428b9. https://doi.org/10.1097/01.hs9.0000969464.02428.b9

Authors:

Barbara Eichhorst

Nicole Lamanna

Susan O’Brien

Constantine S. Tam

Lugui Qiu

Keri Yang

Ken Wu

Tommi Salmi

Gisoo Barnes

Jennifer R. Brown

Affiliated Authors: